Baker Hughes CEO Lorenzo Simonelli Has Sold $47.9M in BKR Stock — $23.4M in a Single Day
Baker Hughes CEO Lorenzo Simonelli sold $47.9M in BKR stock across 113 transactions, including a $23.4M block sale in July 2025. Recent February 2026 filings show 55K-share option exercises.
Lorenzo Simonelli, CEO of Baker Hughes (BKR), has sold $47.9 million in company stock across 113 insider transactions. His July 2025 block sale of 526,568 shares at $44.42 generated $23.4 million in a single transaction — nearly half his career sales total in one day.
The Numbers
| Metric | Value |
|---|---|
| Career Sell Value | $47.9M |
| Career Buy Value | $2.0M |
| Total Transactions | 113 |
| Last Transaction | 2026-02-02 |
| Shares Remaining | 55,886 |
Recent Activity
| Date | Type | Shares | Price | Est. Value |
|---|---|---|---|---|
| 2026-02-02 | Exercise | 55,885 | N/A | $0 |
| 2026-02-02 | Exercise | 55,885 | N/A | $0 |
| 2026-01-30 | Exercise | 38,116 | N/A | $0 |
| 2026-01-30 | Exercise | 38,116 | N/A | $0 |
| 2026-01-26 | Exercise | 50,857 | N/A | $0 |
Simonelli's January-February 2026 filings show repeated option exercises of 38K-56K share blocks without corresponding sales, suggesting he may be accumulating shares from vesting grants. The contrast with his massive July 2025 sell-off raises questions: is the CEO rebuilding his position after a major liquidation event, or are these exercises preceding future sales?
What It Means
The $23.4M single-day sale in July 2025 dominates Simonelli's insider trading profile. Selling half your career total in one transaction suggests either a large options tranche approaching expiration or a deliberate decision to monetize during BKR's strong energy sector performance. Baker Hughes has been a beneficiary of sustained oilfield services demand and its pivot toward energy transition technology.
With 55,886 shares remaining after the February 2026 exercises, Simonelli maintains a meaningful ~$2.5M+ stake at current prices. The exercise-without-sell pattern in early 2026 could signal renewed confidence in BKR's trajectory — or simply that the exercised options haven't entered their sale window yet. The $2M in career purchases against $47.9M in sales still shows a heavily sell-weighted profile.
What to Watch
- Whether the January-February 2026 exercised shares are sold in coming weeks
- Baker Hughes Q1 2026 earnings and oilfield services demand outlook
- Oil price trajectory and its impact on BKR's equipment orders backlog
- Other Baker Hughes insiders' activity following Simonelli's July 2025 block sale
Related Research
Explore all researchFIL Ltd's Q4 2025 13F shows $133.60B in reported value, led by MSFT and a diversified institutional tail.
Apr 24, 2026
Victory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Raymond James used Q4 2025 to keep broad ETF exposure high through VOO, AGG, SPY and IEFA while also adding to sector sleeves such as XLK and XLE. The next filing will show whether that balanced ETF-heavy structure remains the preferred setup.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Nuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Apr 17, 2026